Traws Pharma

TRAW · NASDAQ

$0.3767+$0.0102 (+2.78%)TodayMarket closed ·
Prev close $0.3665

Who owns TRAW

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 38.4% of TRAW’s shares.

  • OrbiMed Advisors, LLC7.9%
  • Ally Bridge Group NY LLC5.2%
  • Adage Capital Management, L.P.4.8%
  • Adar1 Capital Management LLC3.9%
  • Next 6 largest institutions16.6%
  • All other shareholders61.6%
Top institutional holders of TRAW
HolderShares% of shares
OrbiMed Advisors, LLC1.20M7.90%
Ally Bridge Group NY LLC786.24K5.16%
Adage Capital Management, L.P.730.00K4.79%
Adar1 Capital Management LLC597.73K3.92%
Lynx1 Capital Advisors LLC559.47K3.67%
Chernett (Jorey)543.27K3.57%
Ikarian Capital LLC478.14K3.14%
Sphera Funds Management Ltd.398.49K2.62%
Vanguard Capital Management, LLC330.05K2.17%
Jane Street Capital, L.L.C.216.01K1.42%

Largest mutual fund holders

Top mutual fund holders of TRAW
HolderShares% of shares
Vanguard Total Stock Market Index Fund177.20K1.16%
Vanguard Extended Market Index Fund152.85K1.00%
Fidelity Extended Market Index Fund73.91K0.49%
Fidelity NASDAQ Composite Index Fund17.60K0.12%
Fidelity Series Total Market Index Fund8.10K0.05%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of TRAW in the last 6 months.

Latest TRAW insider transactions
InsiderTypeSharesValue
Pauza Charles DavidAward97.00K—
Savchuk NikolayAward93.00K—
CAUTREELS WERNERAward14.15K—
Parker Charles NolanAward90.00K—
Redfield RobertAward84.00K—
Clarke TraffordAward14.15K—
Shoemaker Mary TeresaAward14.15K—
Dukes Iain D.Award274.00K—
Leaman John HaroldAward14.15K—
STOVER JACK EAward14.15K—

Short interest

Settled Sep 30, 2026

Shares short
690.68K
Days to cover
1.00
% of shares outstanding
4.54%
Average daily volume
2.78M
Change since last report
+12.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.